FBDD Fragments Base Drugs Discovery | Design
  IOTA publishes review with Genentech scientists describing the use of mechanism-informed phenotypic screening (MIPS) in oncology drug discovery
  IOTA Pharmaceuticals in €7.8M consortium tackling neglected parasitic diseases
  IOTA InFarmatik Press Release
  IOTA announces KINOMED, a new partnership to accelerate protein kinase drug discovery Cambridge, UK / Odense, Denmark / Lund, Sweden, February 22, 2011
  New consortium to develop drugs for neglected tropical diseases
  IOTA announces SPR initiative with Beactica AB
  IOTA announces FBDD screening services
  IOTA announces collaboration with Vitas M-laboratory and new FBDD library:IOTA-Vitas 4000
  IOTA Pharmaceuticals established; research centers in the UK, the Netherlands, and India.
  IOTA announces FBDD Initiative with the VU University, Amsterdam
  IOTA announces first FBDD product: IOTA Diverse 1500
IOTA’s UK Design Labs are based in the IT-leading University city of Cambridge.
Built on expertise in the field of large pharma drug design, we offer industry-leading fragment design capabilities. 
Led by the IOTA co-founder Dr Susan Boyd, the design team has extensive experience of working on compchem projects with large and small pharma, as well as international biotech companies. 
Under confidentiality, IOTA offers to design bespoke fragment libraries addressing individual drug discovery targets. We also offer the service of selecting screening compounds from our own and other suppliers fragment libraries for use in target-specific fragment-screening campaigns. 
Our On-line Shop currently offers a Diverse Fragment Library containing over 1000 individual fragments optimised for subsequent medchem. We also offer an FBDD “Starter Kit”. The latter provides a range of fragments experimentally validated to hit specific members of gene families of pharmaceutical interest, and can be used to calibrate your own fragment screens.
Through our in-house screening operations, we also offer experimental screening of fragment libraries against specific target proteins, delivering the resulting screening datasets direct to clients as a service (see IOTA Services).
IOTA Fragment Libraries
FBDD Starter Kit “Diverse 1500” Library Phosphodiesterase Library
Protease Library PDE LibraryGPCR Library
Copyright © 2007 IOTA Pharmaceuticals  |   Site by Dots & Coms